Stonehage Fleming Financial Services Holdings Ltd Invests $1.01 Million in Danaher Corporation $DHR

Stonehage Fleming Financial Services Holdings Ltd bought a new stake in Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 5,317 shares of the conglomerate’s stock, valued at approximately $1,013,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. BlackRock Inc. purchased a new stake in shares of Danaher in the 2nd quarter valued at $10,492,520,000. State Street Corp boosted its holdings in Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after acquiring an additional 472,608 shares during the period. Capital International Investors grew its position in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after acquiring an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Danaher by 9.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after acquiring an additional 1,334,221 shares in the last quarter. Finally, Wellington Management Group LLP increased its stake in Danaher by 11.2% during the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after purchasing an additional 1,517,904 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.2%

DHR opened at $215.74 on Friday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a market cap of $151.67 billion, a P/E ratio of 38.32, a PEG ratio of 2.68 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The business’s 50-day simple moving average is $198.69 and its 200-day simple moving average is $192.35.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.77 earnings per share. As a group, equities research analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Wells Fargo & Company dropped their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. HSBC reduced their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Citigroup began coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective on the stock. Finally, Stifel Nicolaus reduced their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.